New Delhi: Feb 18, 2011
The proposal for conducting the now controversial “Post-licensure observational study of Human Papilloma Virus (HPV) vaccination: Demonstration Project,” carried out by a non-governmental organisation PATH for two major pharmaceutical companies, had been turned down by the Public Health Foundation of India (PHFI) as it failed to state the ethical aspects involved in it. The PHFI had received the proposal for conducting the study from the Indian Institute of Public Health at Gandhi Nagar (Gujarat) but the Institutional Ethics Committee of the Foundation rejected it on the grounds that it was “based on the assumption that no ethical issues arise with regard to undertaking the HPV vaccine demonstration project.''
Read more
The proposal for conducting the now controversial “Post-licensure observational study of Human Papilloma Virus (HPV) vaccination: Demonstration Project,” carried out by a non-governmental organisation PATH for two major pharmaceutical companies, had been turned down by the Public Health Foundation of India (PHFI) as it failed to state the ethical aspects involved in it. The PHFI had received the proposal for conducting the study from the Indian Institute of Public Health at Gandhi Nagar (Gujarat) but the Institutional Ethics Committee of the Foundation rejected it on the grounds that it was “based on the assumption that no ethical issues arise with regard to undertaking the HPV vaccine demonstration project.''
Read more
RSS Feed
